Search Orphan Drug Designations and Approvals
-
Generic Name: | glatiramer acetate |
---|---|
Date Designated: | 11/14/2007 |
Orphan Designation: | Treatment of amyotrophic lateral sclerosis (ALS). |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Teva Neurosciences, Inc. P. O. Box 1005 Horsham, Pennsylvania 19044 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-